PMV Pharmaceuticals, Inc.

8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Results of operations (earnings release) Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 6, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Regulation FD disclosure; Other events Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) May 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Terminated a material agreement; Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Exit or disposal costs; Regulation FD disclosure Jan 18, 2024 8-K Director or officer change; Regulation FD disclosure Jan 5, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Other events Oct 12, 2023 8-K Regulation FD disclosure Oct 11, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Aug 9, 2023 8-K Shareholder vote results Jun 9, 2023 10-Q Quarter ended 2023-03-31 May 10, 2023 8-K Results of operations (earnings release) May 10, 2023 8-K Amended charter or bylaws Apr 28, 2023 10-K Fiscal year ended 2022-12-31 Mar 1, 2023 8-K Results of operations (earnings release) Mar 1, 2023 10-Q Quarter ended 2022-09-30 Nov 8, 2022 8-K Results of operations (earnings release) Nov 8, 2022